Philip Morris
Tobacco Withdrawal in Self - Quitters
Fields
- Author
- Hughes, J.R.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- Area
- WORLDWIDE REG AFFAIRS/LIBRARY
- Site
- N403
- Named Organization
- Univ of Vt
- Named Person
- Badger, G.
- Cruser, K.
- Fenwick, J.
- Flynn, B.
- Goodwin, G.
- Hughes, J.R.
- Pepper, S.
- Shea, P.
- Solomon, L.
- Valliere, W.
- Request
- Stmn/R1-036
- Stmn/R1-072
- Stmn/R1-073
- Stmn/R4-005
- Author (Organization)
- Journal of Consulting + Clinical Psychol
- Natl Heart Lung + Blood Inst
- Natl Inst on Drug Abuse
- Univ of Vt
- Master ID
- 2046398862/0490
- 2046398862-8874 Submission of Phillip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Iots Meeting on 940802 Volume 3.01
- 2046398875 2
- 2046398876-8886 Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Dsm-IV
- 2046398887 3
- 2046398888-8892 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition - Revised) Dsm-III-R
- 2046398893 4
- 2046398894-8897 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition)
- 2046398898 5
- 2046398899-8901 What Makes US Run?
- 2046398902 6
- 2046398903-8931 Chapter 5 the Neurochemical Mechanisms Underlying Nicotine Tolerance and Dependence
- 2046398932 7
- 2046398933-8994 8. The Psychopharmacological and Neurochemical Consequences of Chronic Nicotine Administration
- 2046398995 8
- 2046398997-8999 Establishing A Nicotine Threshold for Addiction
- 2046399000 9
- 2046399001-9006 Intravenous Nicotine Replacement Suppresses Nicotine Intake From Cigarette Smoking
- 2046399007 10
- 2046399008-9013 Daily Intake of Nicotine During Cigarette Smoking
- 2046399014 11
- 2046399015-9022 Stable Isotope Studies of Nicotine Kinetics and Bioavailability
- 2046399023 12
- 2046399024-9060 Biobehavioral Approaches to Smoking Control
- 2046399061 13
- 2046399062-9064 Brief Communication Preference Among Research Cigarettes with Varying Nicotine Yields
- 2046399065 14
- 2046399066-9076 Slip-Ups and Relapse in Attempts to Quit Smoking
- 2046399077 15
- 2046399078-9100 Drug Addiction As A Psychological Process
- 2046399101 16
- 2046399102-9113 Population Characteristics and Cigarette Yield As Determinants of Smoke Exposure
- 2046399114 17
- 2046399115-9123 Smoking History, Cigarette Yield and Smoking Behavior As Determinants of Smoke Exposure.
- 2046399124 Andrews Office Products Capitol Heights, Md (K) 18
- 2046399125-9216 Out of the Shadows Understanding Sexual Addiction Second Edition
- 2046399217 Andrews Office Products Capitol Heights, Md (K) 19
- 2046399218-9220 Morbidity and Mortality Weekly Report Progress in Chronic Disease Prevention Smoking Cessation During Previous Year Among Adults - United States, 900000 and 910000
- 2046399221 Andrews Office Products Capitol Heights, Md (K) 20
- 2046399222-9224 Research Report Can Carrots Be Addictive? An Extraordinary Form of Drug Dependence
- 2046399225 Andrews Office Products Capitol Heights, Md (K) 21
- 2046399226-9233 Running Addiction: Measurement and Associated Psychological Characteristic
- 2046399234 Andrews Office Products Capitol Heights, Md (K) 22
- 2046399235-9252 Goth's Medical Pharmacology
- 2046399253 Andrews Office Products Capitol Heights, Md (K)
- 2046399254-9272 An Analysis of the Addiction Liability of Nicotine
- 2046399273 Andrews Office Products Capitol Heights, Md (K) 24
- 2046399274-9283 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399284 Andrews Office Products Capitol Heights, Md (K) 25
- 2046399285-9288 the Effect of Running on Plasma Beta-Endorphin
- 2046399289
- 2046399290 Library Copy: Please Return
- 2046399291 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.02
- 2046399292 21 Andrews Office Products Capitol Heights, Md (K)
- 2046399293-9300 Running Addiction: Measurement and Associated Psychological Characteristics
- 2046399301 22 Andrews Office Products Capitol Heights, Md (K)
- 2046399302-9319 Goth's Medical Pharmacology Drug Abuse and Dependence
- 2046399320 23 Andrews Office Products Capitol Heights, Md (K)
- 2046399321-9339 An Analysis of the Addiction Liability of Nicotine
- 2046399340 24 Andrews Office Products Capitol Heights, Md (K)
- 2046399341-9350 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399351 25 Andrews Office Products Capitol Heights, Md (K)
- 2046399352-9355 the Effect of Running on Plasma B-Endorphin
- 2046399356 26 Andrews Office Products Capitol Heights, Md (K)
- 2046399357-9375 Shopaholics Serious Help for Addicted Spenders Chapter 3 Nature of Addiction
- 2046399376 27 Andrews Office Products Capitol Heights, Md (K)
- 2046399377-9380 Effect of Transdermal Nicotine Delivery As An Adjunct to Low-Intervention Smoking Cessation Theraphy
- 2046399381 28 Andrews Office Products Capitol Heights, Md (K)
- 2046399382-9394 Measuring Nicotine Dependence: A Review of the Fagerstrom Tolerance Questionnaire
- 2046399395 29
- 2046399396-9419 Tolerance Withdrawal and Dependence on Tobacco and Smoking Termination
- 2046399420 30 Andrews Office Products Capitol Heights, Md (K)
- 2046399421-9426 Methods Used to Quit Smoking in the United States Do Cessation Programs Help?
- 2046399427 31 Andrews Office Products Capitol Heights, Md (K)
- 2046399428-9434 Effect of Transdermal Nicotine Patches on Cigarette Smoking A Double Blind Crossover Study
- 2046399435 32
- 2046399435A Symposium Smoking Cessation: A Comparison of Aided Vs. Unaided Quitters / Attempters. Predictors of Early Relapse.
- 2046399436 33
- 2046399437-9448 Mind Matters How Mind and Brain Interact to Create Our Conscious Lives
- 2046399449 34
- 2046399450-9452 Cigarette Craving, Smoking Withdrawal, and Clonidine
- 2046399453 35
- 2046399454-9456 Psycological and Pharmacological Influences in Cigarette Smoking Withdrawal: Effects of Nicotine Gum and Expectancy on Smoking Withdrawal Symptoms and Relapse
- 2046399457 36
- 2046399458-9463 Crs Report for Congress Cigarette Taxes to Fund Health Care Reform: An Economic Analysis
- 2046399464 37
- 2046399465-9472 22.4 Caffeine and Tobacco Dependence
- 2046399473 38
- 2046399474-9476 Pinball Wizard: the Case of A Pinball Machine Addict
- 2046399477 39
- 2046399478-9492 Reviews Caffeine Physical Dependence: Review of Human and Laboratory Animal Studies
- 2046399493 40
- 2046399494-9498 Brief Report Reactions to Withdrawal Symptoms and Success in Smoking Cessation Clinics
- 2046399499 41
- 2046399500-9505 Nicotine or Tar Titration in Cigarette Smoking Behavior?
- 2046399506 42
- 2046399507-9511 Brief Report Blood Nicotine, Smoke Exposure and Tobacco Withdrawal Symptoms
- 2046399512 43
- 2046399513-9523 Conference Report Involvement of Tobacco in Alcoholism and Illicit Drug Use
- 2046399524 44
- 2046399525-9535 Pharmacologic Basis and Treatment of Cigarette Smoking
- 2046399536 45
- 2046399537-9550 'chocolate Addiction': A Preliminary Study of Its Description and Its Relationship to Problem Eating
- 2046399551 46
- 2046399552-9562 Smoking Cessation Methods: Recommendations for Health Professionals. Advisory Group of the European School of Oncology
- 2046399563 47
- 2046399564-9574 Nicotine Yield As Determinant of Smoke Exposure Indicators and Puffing Behavior
- 2046399575 48
- 2046399576-9581 Psychological Analysis of Establishment and Maintenance of the Smoking Habit
- 2046399582 49
- 2046399583-9586 Seminars in Respiratory Medicine Appetitive Functions and Dysfunctions: Tobacco
- 2046399587 Andrews Office Products Capitol Heights, Md (K)
- 2046399588 Endorphins, Eating Disorders and Other Addictive Behaviors
- 2046399589-9621 the Clinical Phases of Anorexia Nervosa and Their Relevance to Endorphin Addiction
- 2046399622 51
- 2046399623-9632 Pharmacotheraphy for Smoking Cessation: Unvalidated Assumptions, Anomalies, and Suggestions for Future Research
- 2046399633 52
- 2046399634-9641 Risk - Benefit Assessment of Nicotine Preparations in Smoking Cessation
- 2046399642 53
- 2046399643-9650 Should Caffeine Abuse, Dependence, or Withdrawal Be Added to Dsm - IV and Icd - 10?
- 2046399651 54
- 2046399661 55
- 2046399662-9669 Symptoms of Tobacco Withdrawal A Replication and Extension
- 2046399670
- 2046399671-9763 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.03 Effects of Abstinence From Tobacco A Critical Review
- 2046399764 57
- 2046399765-9769 Reports From Research Centres - 21 Human Behavioral Pharmacology Laboratory University of Vermont
- 2046399770 58
- 2046399771 Withdrawal Symptoms and Smoking Cessation
- 2046399772 59
- 2046399773-9778 Nicotine Vs Placebo Gum in General Medical Practice
- 2046399779 60
- 2046399780-9783 Prevalence of Tobacco Dependence and Withdrawal
- 2046399784 61
- 2046399785-9790 Signs and Symptoms of Tobacco Withdrawal
- 2046399791 62
- 2046399792-9798 Patterns and Predictors of Smoking Cessation Among Users of A Telephone Hotline
- 2046399799 63
- 2046399800-9820 Current Concepts of Addiction
- 2046399821 64
- 2046399822-9861 the American Academy of Psychiatrists in Alcoholism and Addictions 910000 Annual Meeting
- 2046399862 65
- 2046399863-9915 the Pharmacological Basis of Therapeutics Eighth Edition Chapter 22 Drug Addiction and Drug Abuse
- 2046399916 66
- 2046399917-9953 1 Tobacco Smoking and Nicotine Dependence
- 2046399954 67
- 2046399955-9957 Commentary Trivializing Dependence
- 2046399958 68
- 2046399959-9968 the Favorite Cigarette of the Day
- 2046399969 69
- 2046399970-9971 Overview: Alternative Forms of Pharmacologic Treatment
- 2046399972 70
- 2046399973-9974 British Medical Journal No 6891 Volume 306
- 2046399975 71
- 2046399976-9981 Original Contributors Predicting Smoking Cessation Who Will Quit with and Without the Nicotine Patch
- 2046399982 72
- 2046399983-0019 the Selling of Dsm the Rhetoric of Science in Psychiatry
- 2046400020 73
- 2046400021-0028 the Nosology of Abuse and Dependence
- 2046400029 74
- 2046400030-0035 Use and Misuse of the Concept of Craving by Alcohol, Tobacco, and Drug Researchers
- 2046400035A
- 2046400036-0045 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802
- 2046400046 75
- 2046400047-0048 What Researchers Make of What Cigarette Smokers Say: Filtering Smokers' Hot Air
- 2046400049 76
- 2046400050-0055 the Use of Flavor in Cigarette Substitutes
- 2046400056 77
- 2046400057-0060 Failure to Support the Validity of the Fagerstrom Tolerance Questionnaire As A Measure of Physiological Tolerance to Nicotine
- 2046400061 78
- 2046400062-0067 Effects of Cigarette Smoking on Electrodermal Orienting Reflexes to Stimulus Change and Stimulus Significance
- 2046400068 79
- 2046400069-0074 Behavioral (Non-Chemical) Addictions
- 2046400075 80
- 2046400076-0078 Nicotine Infused Into the Nucleus Accumbens Increases Synaptic Dopamine As Measured by in Vivo Microdialysis
- 2046400079 81
- 2046400080-0085 the Chemistry of Craving
- 2046400086 82
- 2046400087-0102 the Disease Controversy Revisited: An Ontologic Perspective
- 2046400103 83
- 2046400104-0134 A Psychopharmacological and Psychophysiological Evaluation of Smoking Motives
- 2046400135 84
- 2046400136-0146 Predictors and Reasons for Relapse in Smoking Cessation with Nicotine and Placebo Patches
- 2046400147 85
- 2046400148-0155 Clinical Trials and Therapeutics Nasal Spray Nicotine Replacement Suppresses Cigarette Smoking Desire and Behavior
- 2046400156 86
- 2046400157-0163 Predictors of Smoking Cessation in A Sample of Italian Smokers
- 2046400164 87
- 2046400165-0167 Clarification and Standardization of Substance Abuse Terminology
- 2046400168 88
- 2046400169-0179 the Role of Nicotine in Tobacco Use
- 2046400180 89
- 2046400181-0186 Pharmacoepidemiology and Drug Utilization How the Steady - State Cotinine Concentration in Cigarette Smokers Is Directly Related to Nicotine Intake
- 2046400187 90
- 2046400188-0192 Transdermal Nicotine As A Strategy for Nicotine Replacement
- 2046400193
- 2046400194-0198 Sensory Blockade of Smoking Satisfaction
- 2046400199 92
- 2046400200-0204 Brief Report Subjective Response to Cigarette Smoking Following Airway Anesthetization
- 2046400205 93
- 2046400206-0212 Intervention Strategies for Smoking Cessation the Role of Oncology Nursing
- 2046400213 94
- 2046400214-0219 Reduction of Tar, Nicotine and Carbon Monoxide Intake in Low Tar Smokers
- 2046400220 95
- 2046400221-0234 Long-Term Switching to Low-Tar Low-Nicotine Cigarettes
- 2046400235 96
- 2046400236-0239 Comment Recidivism and Self-Cure of Smoking and Obesity: An Attempt to Replicate
- 2046400240 97
- 2046400241-0249 Recidivism and Self-Cure of Smoking and Obesity
- 2046400250 98
- 2046400251-0263 Public Forum Love: Addiction or Road to Self-Realization, A Second Look
- 2046400264 99
- 2046400265-0274 Pharmacological and Non-Pharmacological Smoking Motives: A Replication and Extension
- 2046400275 100
- 2046400276-0289 Overcoming the Loss of A Love: Preventing Love Addiction and Promoting Positive Emotional Health
- 2046400290 101
- 2046400291-0298 the Health Benefits of Smoking Cessation A Report of the Surgeon General
- 2046400299 102
- 2046400300-0338 the Health Consequences of Smoking Nicotine Addiction A Report of the Surgeon General
- 2046400339 103
- 2046400340-0357 the Health Consequences of Smoking Chronic Obstructive Lung Disease A Report of the Surgeon General Chapter 6. Low Yield Cigarettes and Their Role in Chronic Obstructive Lung Disease
- 2046400358 104
- 2046400359 Smoking and Health Report of the Advisory Committee to the Surgeon General of the Public Health Service
- 2046400360-0369 Chapter 13 Characterization of the Tobacco Habit
- 2046400370 105
- 2046400371-0375 Is Nicotine Use An Addiction
- 2046400376 106
- 2046400377-0391 Nicotine Pharmacodynamics: Some Unresolved Issues
- 2046400392 107
- 2046400393-0400 Craving for Cigarettes
- 2046400401 108
- 2046400402 Smoker Motivation A Review of Contemporary Literature
- 2046400403-0453 Chapter 1 Trends in Cigarette Consumption and the Sociodemographic Structure of the Smoking Population in Developed Industrial Countries
- 2046400454 109
- 2046400455-0461 Increase of Circulating Beta-Endorphin-Like Immunoreactivity Correlates with the Change in Feeling of Pleasantness After Running
- 2046400462 110
- 2046400463-0469 New Data Note Series - 20 Severity of Dependence: Data From the Dsm-IV Field Trials
- 2046400470 111
- 2046400471-0479 World Health Organization Technical Report Series No. 551 Who Expert Committee on Drug Dependence Twentieth Report
- 2046400480 112
- 2046400481-0489 Cigarette Brand-Switching: Effects on Smoke Exposure and Smoking Behavior
- 2046400490
Related Documents:
Document Images
Journal ofConsuiUnti and Climeal Psveholo{Y CopYright 199: b, the American Ps~enoioucai assurae^n
lac
`-, t9G:. voi b0. ~0 5.6E9-697 ,
I
I
I
I
I
i
I
I
I
I
I
I
I
I
I
I
I
Tobacco Withdrawal in Self-Quitters
John R. Hughes
Departments of Psychiatrv Psychology, and Family Practice
University of Vermont
Self-reported and observer-rated signs and symptoms of nicotine withdrawal were assessed preces-
sati.on and 2, 7,14, 30, 90, and 180 days postcessauon in smokers who quit on their own for 30 days.
Anxiety, difficulty concentrating, hunger, irritability, restlessness, and weight gain increased,
and
heart rate decreased, postcessation (p <.001). Except for hunger and weight gain, these symptoms
returned to precessation levels by 30 days postcessation. Craving, depression, and alcohol or caf-
feine intake did not reliably increase. Postcessation depression, but not withdrawal symptoms.
craving, or weight gain, predicted relapse. These results are consistent with prior studies.
Cessation of smoking typically produces irritabilitx anxietx
nocturnal awakening, depression, difficulty concentrating,
hunger, restlessness, impatience, and a strong desire (i.e, crav-
ing) for nicotine (American Psychiatric Association, 1987;
Hughes, Higgins, & Hatsukami, 1990). Cessation also de-
creases heart rate and increases weight (American Psychiatric
Association, 1987; Hughes et a1,1990). These signs and symp-
toms are reliable (Httghes, Hatsukami, Pickens, & Svikis,
1984), observable by others (Hughes, Gust, Skoog, Keenan, &
Fenwick,1991; Hughes & Hatsukami, 1986), and may be clini-
cally significant jHughes & Hatsukami, 1986). Many of these
appear to be withdrawal effects in that they are time limited
(Hughes et a1,1991; Hughes et a1,1990). Many also appear to
be due to deprivation of nicotine in that they are relieved by
nicotine replacement (Fagerstrom, 1988; Hughes et al, 1991)
and occur with cessation of nicotine gum (Hughes, Hatsukami,
& Skoog, 1986; West & Russel1,1985).
With one exception (Gritz, Carr, & Marcus, 199 1), prospec-
tive studies of abstinence effects have been restricted to the
fewer than 5% of smokers who quit through treatment pro-
grams (Fiore et a1,1990). Such smokers differ from average U.S
smokers who quit on their own in several respects (Fiore et al,
1990). Importan* they appear to be more dependent than
self-quittets: for example, they smoke more cigarettes (Fiore et
al,1990) and score higher on dependencx scales (Russell, Peto,
& Pate1,1974).
Prior prospective studies of withdrawal have also failed to
include adequate control groups of nonsmokers or continuing
This study was funded by Grant HL-39220 from the National Heart,
Lung, and Blood Institute and Research Scientist Development Award
DA-00109 to John R. Hughes from the National Institute on Drug
Abuse.
I thank Kevin Cruser, Pam Shea, William Valliere, Sara Pepper,
Laura Solomon, and Brian Flynn for their help in conducting the studyc
I thank Greg Goodwin, Gary Badger, and Jim Fenwick for their help
with the analyses.
Correspondence concerning this article should be addressed to John
R. Hughes, Department of PsychiatrX Human Behavioral Pharmacol-
ogy Laborztory4 University of Vermont, 38 Fletcher Place, Burlington,
Vermont 05401-1419.
smokers (Hughes et al, 1990). These groups are necessary to
test "withdrawal" versus "self-medication" interpretations of
postcessation effects (Goldstein, 1987; Mangan & Golding,
1984). For example, consider anxiety scores. Withdrawal would
be inferred if precessation values among smokers were similar
to those of nonsmokers and abstinence values of smokers were
greater than those of nonsmokers. Self-medication would be
inferred if precessation scores among smokers were less than
those of nonsmokers and abstinence values of smokers were
equal to those of nonsmokets.
The present study examined the validity reliability, inci-
dence, magnitude, and time course of nicotine withdrawal in
persons who attempted to stop smoking without treatment.
Control groups of continuing smokers, never-smokers, and
long-term ex-smokers were included. The study also examined
reasons for variability in the severity of nicotine withdrawal
and whether severe withdrawal prospectively predicted relapse.
Method
Another article reports the recruitment methods, subject flow, sam-
ple characteristics, and cessaiion rates in mote detail (Hughes et al, in
press). The present article focuses on withdrawal effects.
Subjects
Subjects were obtained through newspaper and radio advertise-
menu throughout Vermont and nearby upstate New York, western
New Hampshire, and western Massachusetts. The ads recruited
smokers who were about to quit on their own and offered brief tele-
phone counseling and payment (S20 per hour) for filling out forms.
Subjects were unaware of the amount of payment until after entering
the studx
Because this was a study of the effects of abrupt cessation in regular
smokers, we excluded individuals who were not smoking daily, had
n:ceatly reduced their smoking by 50%, had recently switched to a
low-nicotine cigarette, were planning on stopping through gradual re-
duction, or had littk motivation for cessation. Among the 1,396 indi-
viduals screetted. 566 (41%) were excluded by one or more of these
criteria. Those included and excluded did not differ on demographics
or smoking history variables.
The 830 remaining potential subjects gave informed consent. They
named two observers who were 18 years old or older and who saw the
689

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
690 JOHN R. HUGHES
subject at least 3 hours per day. 5 days per week. One of the observers in
each pair was called to verify how much he or she saw the potential
subject. to obtain the observer's consent to periodically rate the subject
on several behaviors, and to verify abstinence or smoking, for which he
or she was paid 53.
Among the potential subjects. 630 (76% of 830) were reached for
precessatton interviews and still had plans to stop smoking in the next
2 to 10 days. Those reached and not reached for precessation interviews
did not differ on demographics or smoking history variables.
Among the 630 individuals reached, the gender percentages and the
means, and standard deviations (in parentheses) for subject chancter-
istics were the following: 65% were women; age - 38.7 (11.9) years;
cigarettes smoked per day = 26.7 (12.3 ): nicotine yield - 0.85 (0.31) mg
per cigarette; duration of smoking = 21.6 (11.8) years; percentage v, tto
tried to quit in the past = 92%; and Fagerstrom score (Fagerstrom &
Schneider, 1989) = 6.2 (1.8). The Fagerstrom score consists of seven
items concerning nicotine intake (e.g., numberof cigarettes smoked per
day) and behavioral indexes of dependence (e.g., time to first cigarette
after awakening). As delineated in a prior article (Hughes et al., in
pt ess), these subjects were similar to subjects in other studies of self-
quitters (Cohen et al" 1989), except that the proportion of women was
greater in the present study.
Procedures
At the precessation interview, subjects were asked to rate a set of
symptoms and behaviors composed of nicotine withdrawal effects (see
Table 1) plus some filler symptoms (e.g, feel better about myself).
These were listed in random order and labeled as a"behavior check-
list" rather than as a withdrawal scale. Observers completed a similar
scale, but several items were deleted as pilot work indicated observers
could not rate these reliably (Hugheset a1.1991; Hughes, Hattukami,
Pickens. Krahn, et al.,1984). The behaviors were rated for the last 24
hours from 0= none, 1- mild, 2= moderate, to 3- seven. These
self-report and observer scales previously have been shown to be sensi-
tive to the effects of abstinence and of nicotine replacement (Hughes &
Hatsukami, 1986; Hughes et al, 1990, Hughes, Hatsumaki. Pickens,
Krahn. et al.. 1984; Hughes et a1.,1991).
Subjects were also mailed a two-paragraph instruction sheet and an
illustration on how to take one's right carotid pulse. At each telephone
contact, subjects took their pulse for 30 s on two occasions. In a pilot
study of 25 subjects using this technique, intrarater stability was 0.77
and interrater agreement with a trained technician's simultaneous pal-
pation of the radial pulse was also 0.77. In addition, subjects did not
systematically report higher or lower pulse rates than did technicians.
Subjects were given 15 min to have any questions about quittittg
answered by trained counselors over the telephone. Subjects had pteviy ously been sent a
stop-smoking booklet (Quit and Win; Pechacek, Ar-
ken. & Johnson, 1982). Specific answers to the more common ques-
tions were developed a priori in pilot testing and were similar to those
described elsewhere (Htuba dc Knttks,1986). Subjects were given no
information concerning witbdrawal symptoms and were not advised
in methods that might abate withdta.val (e.g., relaxation). Subjects were
told that no more counseling would be availabk as this was a study of
self-quitting. Subjects set a quit date and informed the interviewer of
this date.
Subjects and observers were contacted by telephone at 2, 7, 14, 30,
90, and l80 days after their quit date, and the behavior checklist and
smoking status were obtained. All subjects whose data are included
were reached within 2 days of these follow-ups. If the subject reported
abstinence at all follow-ups and this report was not refuted by the
observer, a research assistant arranged a home visit within a month of
the I 80-day follow-up. At this visit, a breath sample for carbon monox-
ide and a saliva sample for cotinine were obtained (Jarvis. Tunstall-Pe-
doe. Feyerabend. Vesey, & Saloojee. 198,7).
Control groups of 56 long-term ex-smokers (abstinent for more than
f,vear), 67 current smokers (currently smoked daily), and 61 never-
smokers (never smoked daily for I month) were recruited from the
observers. These subjects were tested initially and then 7 and 30 days
later. These control groups did not differ from each other or from the
subjects, with the exceptions that experimental subjects were slightly
younger than control group subjects (36.1 vs. 36.5-40.1 years, p <.05)
and that never-smokers were slightly more educated than smokers,
current smokers, and experimental subjects (14.3 vs. 13.0-13.6 years,
p < .05).
Data Analysis
The major data analyses used only smokers abstinent at the 2-, 7-,14-,
and 30-day follow-ups. Many smokers who eventually ars abstinent
smoke a few cigarettes on a few days after their quit date. When we
divided subjects into those who smoked some but averaged 1 cigarette
or less per day between fol low-ups (n - 33; M cigarettes per day - 0.20)
and compared them with complete abstainers (n - 145), the total with-
drawal discomfort score (sum of the valid withdrawal symptoms see
Results section) did not differ between the two groups (10.4 vs. 11.1,
p= .38); thus, for this article, subjects who smoked 1 cigarette or less
per day were included.
An earlier publication (Hughes et al., 1991) discussed the pros aad
cons of examining withdrawal effects using cross-sectional analyses of
subjects abstinent at each follow-up versus longitudinal analyses of the
subset of subjects able to remain abstinent for a long period. In the
present studX we chose to do a longitudinal analysis of the 178 subjects
who reported abstinence at 2-, 7-, 14-, and 30-day follow-ups, whose
abstinence was observer verified, and who had complete data for self-
reported withdrawal symptoms. Among these subjects, 110 also bad
complete observer-rati.ng data. For data on 90- and 180-day follow-ups,
we used the 78 subjects who continued to be abstinent at both of these
times as wel l. Expiorntory analyses indicated the incidence and magni-
tude of signs and symptoms were slightly higher (typically <I0% and
<0.5 units, respectively) using cross-sectional rather than longitudinal
amlYses.
The withdrawal scores were ordinal and most of the scores were
skewed with many zero scores: thus, nonparunetric analyses were of-
ten used. Two-tailed p values aie given.
Results
Yalidity and Reliability
A valid symptom was defined as one that was significantly
different during abstinence than during smoking. To test this,
the precessation and follow-up scores for each symptom were
entered into a five-cell (precessation, 2-, 7-, 14-, and 30-day fol-
low-up) one-way Friedman's test. After cessation, anxietx diffi-
culty concentrating, hunger, irritability, restlessness, and
weight gain increased, and heart rate decreased (see Table 1 and
Figure 1). Observer ratings confirmed the findings of anxiety,
irritability4 and restlessness. Post hoc tests comparing postces-
sation scores with precessation scores were performed for those
variables for which the Friedman's test was significant. Bon-
ferroni adjustments were used to control Type I error. AnxietX
difficulty concentrating, irritabilitx and restlessness differed
from precessation only at 2 days postce.ssation; heart rate dif-
I

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
TOBACCO WITHDRAWAL IN SELF-QUITTERS
- Table I
Means and Standard Deviattons of Symptom Scores Among 178
Subjects Abstinent at 2-. 7-. 14-, and 30-Day Follow- Ups
Days postcessauon
Symptom
Precessation
2
7
14
30 Friedman's
test
Self-ratings (0-3: N - 178)
Anxiety
M
1.5
2.1
1.8
1.4
1.2
59.6"
SD 1.2 1.0 1.0 1.1 1.0
Depres4on
M
1.2
1.1
1.2
1.0
0.8
11.6
SD 1.2 1.1 1.0 1.0 0.9
Difficulty concentrating
M
0.9
1.40
1.0
0.7
0.7
32.3"'
SD 1.0 1.1 1.1 0.9 0.9
Hunger
M
0.7
1.6
1.6
1.4
1.3
42.9"
SD 1.0 1.1 1.2 1.2 1.1
Irritability
M
1.6
2.1
1.8
1.6
1.3
31.7"
SD 1.1 1.1 1.0 1.0 1.1
Poor memory
M
0.7
0.8
0.8
0.6
0.6
3.7
SD 1.0 1.0 1.0 0.9 0.9
Restlessness
M
1.4
2.0
1.8
1.4
1.2
56.9°
SD 1.2 1.1 0.9 1.1 1.0
Other self-ratings
Craving(0-100)
M
61.8
57.5
49.2
35.2
27.6
111.6"
SD 24.6 26.6 27.0 25.6 25.0
No. of nocturnal awakenings
M
1.3
1.7
1.3
1.2
1.1
8.7
SD 1.7 1.9 1.8 1.4 1.5
Weight (kg)
M
71.8
71.9
72.3'
72.7'
72.9
43.3"
SD 1.5 15.7 15.7 16.1 16.0
Heart rate (bpm)
M
82.0
76.8
75.1'
75.7
77.6
27.7"
SD 13.1 11.3 10.9 11.1 11.3
Alcohol (drinks/day)
M
0.2
0.2
0.2
0.2
0.2
0.2
SD 0.7 0.8 1.0 0.7 1.1
Caffeine (drinks/day)
M
2.3
2.1
2.3
2.1
2.1
7.2
SD 1.7 1.6 1.9 1.7 1.9
Total withdrawal discomfort score'
M
7.4
10.5
9.0'
7.7
6.6
82.8"
SD 4.2 4.2 4.1 4.2 4.0
Observer ntings(0-3 N ~ 78)
Anxiety
M
1.1
1.7
1.2
1.0
1.0
19.8"
SD 1.0 1.0 1.0 0.9 1.0
Deptession
M
0.6
0.8
0.6
0.7
0.6
3.0
SD 0.9 0.9 0.8 0.9 0.8
~ry
M
1.0
1.7
1.3
1.2
1.3
12.0"
SD 1.1 1.1 1.1 1.1 1.1
Restlessness
M
1.0
1.6
1.3
1.2
1.0
19.4'°'
SD 0.9 1.0 1.0 0.9 1.0
Nae. Abstinence was de5ned as self-reported 1 ci8aitttt or less per day, not refutad by observer. Kg
~
kilograms; bpm = beats per minute.
' Calculated as sum of ratings of anxiety, difficulty concentrating, hunger, irritability,
resdessness, and
nocturnal awakenings.
. p<.01. "p<.001.
691
I

~
3
Anxiety
3-1
Dl/llculty Concentrating
31
Irrllablllly
3-1 Rostl.san.ss ;°
2 a 2
21 a 2 a
C C
a C «
C
w
~ w
~OC w
~ "~'----. ¢ 11 r""~--~-----.------
i
e 0 ~
~...... ae 1 1
JJ' 0 ~ , ..,_, Y,,_.. 0
....ee.. -.-.---y---------.---~.-.-
.,--. _._.._, ~.._ _.- 0 2 7 14 30 90 1ll0
0 2 7 14 30 0 /00 0 2 7 14 30 90 100 0 271/ 30 90 101
Awakening at NiOht
3
s
a
Z
e
a
C
.w.
C .'
. 1
~
w
1R
s 0, . -,
0 2 7 14 30 00 10o
«
100
.
a
H.art Rat.
0 ,., ..,_ ,------,-..____.._
0 27 10 3o tlo t0o 027 14 30 0 /00
0 2 7 14
-- ----
30 90 180
Total Withdrawal Score
Cr.rlno Depression
,i
Ca/lsln.led Serttspes
16
100 3 12
~ w 3 ~. c
a 2 °~
-c
so ° '
~ w C
~ ,
20
~ O TTT'T T
0 .-y ---~--..---..-~- 1 ~r'~~~ o~ 7 14 lo vo I eo
-^~ 0 2 7 11 30 90 100 0= 7 14 30 00 /00
0 0 2 7 14 30 90 180
Fiaurr 1. Self-reported symptoms prc- and postcessation of tobacco use. (The abscissa on each itraph
indicates precessation (0) and days postcessa-
tion. Solid circles and solid lines - subjects abstinent for 30 days[rt-17E1; solid circks and
dotted lines - subjecta abstinent for 180 days (n - 511; open
cincks - current smokers (n - 611; trianj.ks - never smokers [n - 611; open squat+a w bo0-term
ex-smokers [n - 561)
~M6E9V99

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
TOBACCO WITHDRAWAL IN SELF-QUITTERS
fered at 2. 7. and 14 days postcessation: hunger at 2. 7.14. and 30
days postcessation, and weight at 7,14, and 30 days postcessa-
tion.
A total withdrawal discomfort score was calculated by add-
ing scores for anxiety, difficulty concentrating, hunger, irritabil-
ity, restlessness, and nocturnal awakenings. Post hoc tests indi-
cated that the score was significantly greater than precessation
at 2- and 7-day follow-ups, did not differ from precessation at
14-day follow-up, and was lower than precessation at 30-day
follow-up (see Table 1 and Figure 1).
Unexpected}X craving and depression never showed a signifi-
cant increase over time, and craving decreased over time. Alco-
hol and caffeine intake did not change over time. Although
craving and depression were not valid withdrawal symptoms,
because they have been of recent interest (Anda et at., 1990;
Glassman et al, 1990; West & Schneider, 1987), they are dis-
cussed at certain points in this article.
Interrater agreement between the 110 pairs of complete sub-
jects and observers was determined using the 2-day follow-up
scores. To assess agreement across the range of scores, Spear-
man rank order correlations were used. To assess agreement on
whether a score did or did not increase with cessation, kappa
coefficients were used. Kappas were used in preference to chi-
square tests as the former corrects for differences in base rates.
Neither the correlations nor the kappas were large (rs <.30,
Ks <.22). Although subjects tended to rate themselves as hav-
ing a greater symptom intensity than did observe=s, this differ-
ence was not statistically significant.
Table 2
f>srcentage of Subjects Whose Symptom Scores Were Greater at
2-, 7-, 14-, and 30-Day Follow-Ups Than at Precessation
Among Subjects Abstinent For 30 Days
Days postoeaation
Symptom 2 7 14 30
Self-ratings (N - 178)
Anxiety
49
37
30
27
Craving 37 24 17 16
Decreased heart rate (a 1 bpm) 61 64 65 37
Deptnssion 31 38 28 22
Difficulty concenttatina 43 30 20 20
Hunger 53 51 47 45
Irritability 38 38 31 24
Nocturnal a.vakeaings (2 l/night) 39 31 33 27
Restlessness 46 39 35 25
Decreased heart rate (>2 bpm) 61 64 65 5E
WeiEht gain (Z 1 lb or 0.45 kg) 30 53 56 56
Increased affeine (z 1 drink/day) 25 28 27 24
Increased alcohol (x 1 drink/day) 3 7 4, 4
Observer ratings (n - 78r
Anxiety
58
41
29
26
Deptession 38 29 33 28
Irritability 56 39 40 37
Restlessaess 61 45 41 32
Note. Abstinenct was defined as self-reported I cigatette or less per
daX not refuted by observer. Symptoms and follow-ups with percent-
ages in boldface are those whose mean scores differed from ptscessa-
tion means. Lb - pound; kg - kilogramx bpm - beats per minute.
'Ml are rated 0-3 unless otherwise noted.
Incidence, Magnuude, and Y'ariability
693
The peak increase in most self-reported symptoms averaged
from 0.5 to 0.9 of a possible 3 units (Table 1). The magnitude of
the increase in symptoms after cessation was similar across
observer- and self-ratings. The greatest decline in mean heart
rate was 5.2 beats per minute (bpm) at 14-day follow-up. The
greatest increase in mean awakenings at night was 0.5 occur-
rences at 2-day follow-up.
Incidence was calculated for valid symptoms as the percent-
age of subjects whose follow-up score was greater than his or her
precessation score by at least 1 unit for the symptoms, by I
awakening for insomnia, by 2 bpm for heart rate, and by 1
pound (0.45 kg) for weight gain. Incidences for the valid symp-
toms ranged from 37 to 62% across the follow-ups (see Table 2).
Forty-nine percent of abstainers fulfilled Diagnostic and Statu-
tical Manual ojMenta! Disorders (rev 3rd ed4 DSM-III-R) crite-
ria for nicotine withdrawal (American Psychiatric Association,
1987) at 2 days postcasation, 37% at 7 days, 28% at 14 days, and
18% at 30 days postcessation (The DSM-111-R criteria of occur-
reace within 24 hours was assumed to be present in all subjects.)
Relationship Among Signs and Symptoms
Interrelationships among symptoms was examined at 7 days
postcessation, because this was when the largest number of
effects occurred. At this point, increases in anxietX difficulty
concentrating, irritabilitx and restlessness were intercorrelated
(rs =.46-68). Changes in heart rate, hunger, weight, and in-
somnia were not highly correlated among themselves or with
changes in other withdrawal variables (rs <.26). Similar interre-
lationships occurred at 2- and 14-day follow-ups.
Factor analysis of withdrawal at 7 days postcessation used a
principle-components analysis for initial factor extraction fol-
lowed by a varimax rotation. This analysis indicated three fac-
tors: Mood (anxietyy, difficulty concentrating, irritabilitX and
restlessness); Appetite (hunger and weight gain); and Insomnia
(awakenings at night). The Mood factor explained 39% of the
variance. The Appetite and Insomnia factors each added 12%;
thus, a total of 63% of the variance could be explained.
Increases in craving were correlated with increases in the
other mood symptoms and depression (rs =.34-50) but not
with changes in heart rate or weight. Increases in depression
were correlated with increases in irritability and anxiety (rs =
.41-45) but not with changes in other symptoms.
Time Course
Anxiety difficulty concentrating, irritabilitX restlessness,
and nocturnal awakening showed a time-limited increase (see
Figure 1). By 30 days postcessation, these had returned to pre-
cessation levels and were similar to values for the control
groups. Hunger showed a similar time-limited effect but re-
mained elevated at 30 days postcessation. Weight showed a grad-
ual increase toward weights similar to those of long-term ex
smokess. Heart rate showed a decrease at 2-, 7-, and 14-day
follow-ups. Although heart rate appeared to increase again at
30- and 180-day follow-ups, whether the increase was real is
unclear. -
I

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
694
71 0. 9
14
Long-Term Svmptoms
In the 78 subjects who remained abstinent for 180 days,
weight remained an average of 3.2 pounds above precessation
values at 180 days postcessation (Wilcoxon signed ranks test,
p<.04). and 39% of these abstinent smokers had gained 5 or
more pounds since cessation. Craving persisted but declined
over time and did not approach that of never- and ex-smokers
(i.e., zero ratings) until 180 days postcessation. At 180-day fol-
low-up, 51 % of the abstinent smokers reported some craving for
tobacco in the past 24 hours.
Determinants of Abstinence Effects
The precessation items of sex, education, occupation, mari-
tal status, income, cigarettes smoked per dax nicotine yield of
cigarette, duration of smoking, total and item scores for the
Fagerstrom Tolerance Questionnaire, and baseline symptom
scores were correlated with (a) the total withdrawal (i.e., change)
score at 7-day follow-up, (b) total withdrawal score at 30-day
follow-up (to examine duration of withdrawal), (c) craving at 7-
and 30-day follow-ups, and (d) weight gain at 30- and 180-day
follow-ups. The only substantial covariation (e.g., r>.20) was
By 2-day Depression Scor.
,a,
JOHN R. HUGHES
1N
By 14-day Depression Score
IN,
a
M
Ma
m
m
. O
t
that precessation scores of the individual signs and symptoms
were inversely related to the increase in scores at 7 days postab-
stinence (rs =-.49 to -.69, ps < .0 1). The one exception was
weight (r = -.12, ns).
Abstinence Effects and Smoking Cessation
The ability of the individual withdrawal signs and symptoms
and the total scores to predict abstinence at subsequent follow-
ups was tested. Although some of the withdrawal symptoms
predicted outcome at some follow-ups, none consistently pre
dicted outcome across follow-ups in a meaningful manner. Al-
though not a valid withdrawal symptom, depression did consis-
tently predict abstinence across follow-ups (see Figure 2). To
illustrate this, at each follow-up, abstinent smokers were di-
vided into those whose depression scores had increased post-
cessation and those whose follow-up scores were unchanged or
had decreased since precessation. I then compared survival
curves between these two groups. Subjects whose depression
score increased at 2-day follow-up were more likely to later
relapse than those whose depression score remained the same
or decreased at 7-day follow-up (log rank X2 (1, N= 290) = 6.8,
p < .009). Similar effects occurred for the increase in depres-
By 7-day Depression Scor.
IN
14
m
1N
By 30-day Depression Scor.
ta,
M .i
M
M
M
Days Post-Cessatton
ts
e.P-+ a r.«.dM
---fl-- rW...w ..4.mr
r pfewMw
I Ffgure 2. Depression scores in abstinent smokers who later relapsed or remained abstinent.

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
TOBACCO WITHDRAWAL IN SELF-QUITTERS
sion at 7-day (X' (1, 236) = 4.0. p < .05 ), 14-day (X2 (1. ,V =
198)=6.0,p<.01),and30-day(X2(1,N=171)=3.9,p<.05)
follow-ups. However, the difference in the relative rates of re-
lapse in subjects who did and did not have increases in depres-
sion was small (10-15%). When the few subjects with more ex-
treme increases in depression scores (increased 2 or 3 units; n=
40) were examined, the ability of depression to predict relapse
did not increase substantially. When absolute precessation de-
pression scores or absolute postcessation depression scores
were used (instead of change scores), a similar but again less
robust predictive effect occurred. Craving, weight gain, and
total withdrawal discomfort did not consistently predict re-
lapse.
Discussion
Anxietx difficulty concentrating, hunger, irritabilitX rest-
lessness, weight gain, and decreased heart rate were valid signs
and symptoms of nicotine withdrawal in self-quitters. In addi-
tion, awakening at night showed a nonsignificant increase post-
cessation. The increases in anxietx irritabilitX and restlessness
were confirmed by observer ratings. Craving, depression, im-
paired memory; and changes in alcohol or caffeine intake were
not verified as abstinence effects in this sample.
Prior prospective studies of nicotine withdrawal have used
the 5% of smokers who attend formal smoking cessation pro-
grams'(Hughes et al, 1990). The one exception is a study that
followed self-quitters at 1, 2, 7, 30,180, and 365 days postcessa-
tion (Gritz et af, 1991). Valid symptoms in the present study
correspond well with the seven most prevalent symptoms in
this prior study (i.e., anxiety or tension, difficulty concentrat-
ing, excessive hunger, eating more than usual, irritability or
anger, restlessness, and impatience). The prior study used abso-
lute postcessation scores rather than diffetencx scores (absti-
nence minus precessation) and cross-sectional rather than lon-
gitudinal analyses. However, if the present data are reanalyzed
using postcessation scores and cross-sectional analyses, inci-
dence rates similar to this prior study are obtained.
The present results are also comparable with two prior stud-
ies that differed in subjects and settings but used very similar
experimental procedures, withdrawal scales, follow-ups, and
data analysis (Hughes et a1.,1991: Hughes & Hauukami,1986).
The major differences were that in the prior studies subjects
were volunteers for double-blind studies of nicotine gum, were
randomized to placebo gum, and completed mailed question-
naires rather than tdephone interviews. One study consisted of
50 volunteers wbo attended a behavior therapy cessation pro-
gtam (Hughes & Hatsukami,1986). The other study examined
105 general medical practice outpatients who received only
brief advice regarding quitting (Hughes et a1.,1991). W hen simi-
lar time points are compared, withdrawal symptoms appear to
be slightly less prevalent (usually < 10% difference in incidence)
and less intense (usually <0.5 units in change scores) in the
present study than in the first study of program attendees. Re-
sults for the medical outpatients study fell between those of the
present study and those of program attendees.
As in prior studies of tobacco withdrawal, most of the signs
and symptoms in the present study showed a time-limited
course in which symptoms first increased and then decreased
(i.e., a pattern consistent with a drug withdrawal symptom:
Hughes et al, 1990). Depending on the symptom. the mean
scores returned to precessation scores between 7 and 30 days
postcessation (see Figure 1). In the prior study of self-quitters
(Gritz et al., 1991), withdrawal was measured at 7 and 30 days.
By 30-day follow-up, most seemed to stabilize. Other studies of
smokers in cessation programs found that most withdrawal
symptoms declined to precessation levels by 21 to 30 days post-
cessation (Gross & Stitzer.1989; Hughes et al.. 199 I: West. Ha-
jek, & Belcher,1989b). In summarr; the mean duration of nico-
tine withdrawal appears to be 2 to 4 weeks.
Heart rate, hunger, and weight gain appeared to be the excep-
tions to this time coutse. In prior studies, whether heart rate
showed a time-limited, biphasic "withdrawal" pattern or a sim-
ple uniphasic decline postcessation is debatable (Nemeth-Cos-
lett, Sampson, & Henningfield, 1986; Schneider & Jarvik,1985;
Ward, Garvey4 & Bliss, 1992; West & Schneider, 1988). Unfortu-
naiel}4 our results (see Figure 1) do not help resolve the time
pattern for heart rate postcessation.
Hunger appeared to exhibit a prolonged but still time-ii-
mited pattern. This result is consistent with the prior study of
self-quitters (Gritz et a1,1991) and the prior study of medical
outpatients (Hughes et a1.,1991); however, other studies of pro-
gram attendees have found that hunger persists unabated for 4
weeks (West, Hajek, & Belcher, 1987,1989b) to 10 weeks (Gross
& Stitzer,1989).
Weight gain continued throughout the study until at 6
months the mean weight of abstinent smokers appeared to be
similar to that of ex smokers but greater than that of never-
smokers or current smokers. The mean weight gain of 3.2
pounds (1.4 kg) over 6 months is similar to that reported in
prior studies of self-quittets (Klesges, Meyers, Klesges, & La-
Vasque, 1989). The uniphasic pattern of weight gain suggests
that weight gain is due to a simple loss of nicotine's weight-sup-
pressing effects (Grunberg, 1990; Klesges et al. 1989) rather
than to a withdrawal effect. On the other hand, the rate of
weight gain appeared to be greatest in the first 2 weeks and
decreased thereafter, suggesting a time-limited (i.e., with-
drawal-like) potentiation of weight gain.
Craving did not increase after abstinence. As in prior studies
(Hughes et al, 1991; Hughes & Hatsukami, 1986), craving rat-
ings were high precessation: however, the present results do not
appear to be due to ceiling effects as the mean precessation
score was 62 on a 0- to 100-point visual analog scale. These
negative results could be due to the use of the phrase "craving
for cigarettes" rather than "desire for a cigarette" (Kozlowski,
Mann, Wilkinson, & Poulos, 1989) or because the term "crav-
ing" has a different meaning to smokers during smoking than
during abstinence (West & Schneider, 1987). Whatever the rea-
son, in this studx craving failed to show a time-limited increase
characteristic of withdrawal phenomena.
Protracted withdrawal states have been described for alcohol
(DeSoto, O'Donnell, Allred, & Lopes, 1985) and opiates (Mar-
tin & Jasinski, 1969). Most of the symptoms of nicotine with-
drawal showed no evidence of protracted withdrawal. However,
hunger took 3 months to return to baseline, weight gain contin-
ued for 6 months, and craving, although greatly diminished,
persisted in many subjects for 6 months.
As in prior studies (Hughes et al, 1991; Hughes & Hatsu-
I

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
696 JOHN R. HUGHES
kami. 1986). observer ratings were not highly correlated with
self-ratings yet both proved sensitive to abstinence effects. One
possible interpretation of this pattern is that observer and self-
ratings tap different but still valid sets of behaviors.
Several investigators have stated that nicotine withdrawal has
a large between-subjects variability. Comparison of the variabil-
ity in symptomatology in the present study with that found in
studies of alcohol or drug withdrawal is difficult given the dif-
ferent scales used and the different populations studied (i.e.,
self-quitters vs. those who attend a clinic). Thus, whether nico-
tine withdrawal is more variable than other drug withdrawal
syndromes is unclear.
It was hoped that with a larger and more heterogenous popu-
lation than used in prior studies, correlates of individual differ-
ences in nicotine withdrawal could better be detected. How-
ever, as in prior studies (Hughes et al, 1991; Hughes & Hatsu-
kami, 1986), the study was not able to replicate the finding that
the Fagerstrom score predicts more severe withdrawal (Fager-
strom & Schneider,1989). In addition, as in most prior studies
(e.g, Hughes et al, 1990), withdrawal severity did not differ
between men and women or between heavy and light smokers.
A major hypothesis of the nicotine dependence theory is that
nicotine withdrawal prevents abstinence. If this is true, then
subjects with more severe withdrawal should have a greater
probability of relapse. Although some earlier trials have not
confirmed this relationship (Hughes et a1,1991; Hughes & Hat-
sukami. 1986). other trials have (US. Department of Health
and Human Services [USDHHS], 1990). The robustness and
consistency of the predictive power of withdrawal varies sub-
stantially across these studies and across follow-ups within the
studies (USDHHS.1990). It was hoped that the largerand more
heterogenous sample would more likely detect a withdrawal-
abstinence relationship; however, none of the valid withdrawal
symptoms consistently predicted outcome. Subjects with in-
creases in depression were more likely to relapse- This result
replicates and extends the results of two prior studies (Covex
Glassman. & Stetner,1990; West, Hajek, & Belcher,1989a) that
showed that depression predicted short-term (s4 weeks) absti-
nence.
Although the present study replicated prior work indicating
that weight gain does not increase the probability of relapse
(Gross. Stitzer. & Maldanodo,1989; Killen, Fortmann, & New-
man. 1990), it failed to replicate the prior findings of others
(Hall, Ginsberg, & Jones, 1986; Killen, Fortmann, Newman, &
Varad}, 1990) and ourselves (Hughes et al, 1991) that weight
gain decreases the probability of relapse. One possible reason
for the present failure to replicate this latta finding is that the
prior studies used program attendees who gained more weight
and were probably more dependent on nicotine than the self-
quitters in this studyc
The present study had several assets that increased its valid-
ity and generalizability: (a) a large sample, (b) a sample of self-
quitters, (c) few inclusion criteria. (d) several control groups, (e)
previously validated measures, (f) scales sensitive to only large
changes in symptoms, (g) withdrawal scores calculated as
changes from before cessation, and (h) observer ratings.
On the other hand, the study may have suffered from exclu-
sion bias (i.e, perhaps subjects with the most severe withdrawal
returned to smoking and were excluded from the analysis). If
this were true. the present study may have underestimated the
magnitude of withdrawal. The way to prevent exclusion bias is
to experimentally control abstinence (e.g., through large mone-
tary payments): however, this might jeopardize the generaliz-
ability of the findings. Exclusion bias is probably unlikely given
that subjects with more severe withdrawal were not more likely
to relapse in the study. Also, these results may not be generaliz-
able to several groups (i.e., adolescents and subjects who
stopped smoking by gradual reduction, who were involved in
any treatment, or who reported low motivation for cessation
were excluded).
In summary, the results of this study provide new and confir-
matory evidence about nicotine withdrawal; however, the nega-
tive results suggest several questions still to be answered: What
are the determinants of severity of withdrawal? If withdrawal
does not increase the probability of relapse, what does cause
early rel.apse? Nicotine replacement is believed to work by re-
ducing withdrawal (Fagerstrom,1988), yet withdrawal appears
to have little effect on abstinence; thus, how does nicotine re-
placement increase abstinence?
References
American Psychiatric Association. (1987). Diagnostic and statistical
manual of inental disorders (3rd ed_ rev.). Washington, DC: Autbor.
Anda, R. F Williamson, D. F Escobedo, L. G, Mast, E. E, Giovino,
G. A, & Remington, P. L (1990). Depression and the dynamics of
smoking: A national petspectm. Journal of the American Medical
A.tsociatton. 264, 1541-1545.
Cohen, S, Lichtenstein, E, Prochaska, J. O, Rossi, J. S, Gritz, E. R,
Carr, C. R, Orleans, C T Schoenbach, V J, Biener. L, Abnms, Q,
DeClemente, C, Currx S., Martatt, G. A, Cumming, K. M, Emont,
S. L, Giovino, G, & Ossip-Klein, D. (1989). Debunking mythsabout
self-cluitting. American Psychologist, 44. 1355-1365.
Covey, L S, Glassman. A. H.. & Stetner, F. (1990). Depression and
depressive symptoms in smoking cessation. Comprehensive Psychia-
tryc 31. 350-354.
DeSoto. C. B, O'Donnell, W E, Allred. L. J_ & Lopes, C. E(1985).
Symptomatology in alcoholics at various stages ofabstinence. Alco-
holism: Clinical and Ezpenmerual Research. 9, 505-512.
Fagerstrom, K-Q (1988). Efficacy of nicotine chewing gum: A review
In Q F. Pomerleau, C. S. Pomerleau. K-Q Fagerstrom. J. E. Henning-
field, & J. R. Hughes (Eds.). Nicotine replacement: A critical evalua-
tion (pp. 109-128). New York: Alan R. Liss.
Fagetstrom, K-Q, & Schneider. N. G. (1989). Measuring nicotine de-
pendence: A review of the Fagerstrom Tolerance Questionnaire.
Journal of Behavioral Medicine. 12. 159-182.
Fore, M. C, Novomy, T. E, Pierce, J. P Giovino. G. A_ Hatziandreu.
E J, Newcomb, P. A, Surawicz, Z S.. & Davis, R. M. (1990). Meth-
ods used to quit smoking in the United States. Journal ofthe Ameri-
can Medical Association, 263, 2760-2765.
Glassman, A. H, Helzer, J. E, Covex L. S, Cottler, L. B, Stetner. F
Tipp, J. E., & Johnson, J. (1990). Smoking, smoking cessation, and
major depression. Journal of the American MedicalAssocrarion. 264,
1546-1549.
Goldstein, A. (1987). Criteria of a pharmacologic withdrawal syn-
drome. Arrhives of Gentral Psychiatry 44, 392.
Gritz, E. R, Carr, C. R, & Marcus. A. C(1991). The tobacco with-
drawal syndrome in unaided quitters. British Journal of Addiction,
86. 57-69.
Gross. J, & Stitzer, M. L. (1989). Nicotine replacement: Ten-week ef-

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
TOBACCO wtTHDRAWAL IN SELF-QUITTERS
fects on tobacco withdrawal symptoms. Psrchopharmaco/ogi: 98,
331-334.
Gross. J.. Stitzer, M. L., & Maldanodo. J. (1989). Nicotine replacement:
Effects on postcessation weight gain. Journal oiConsulting and Clin-
cal Psvcnologt: S', 87-92.
Grunberg. `. E. (1990). The inverse relationship between tobacco use
and body waght. In L. T Kozlowski. H. Annts. H. D. Cappell. F B.
Glaser, M. Goodstadt, Y. Israel. H. Kalant. E. M. Sellers. & E. R.
Vingilis (Eds). Research advances in alcohol and drug problems (Vol.
10, pp. 273-316). New York: Plenum Press.
Hall. S. M., Ginsberg, D. & Jones, R. T. (1986). Smoking cessation and
weight gain. Journal of Consulting and Clinical Psychology, 54. 342-
346.
Hughes, J. R.. Gulliver. S. B, Fenwick, J. W., Cntser, K.. Valliere, W. A,
Pepper. S. L" Shea, P. J, & Solomon, L. J. (in press). Smoking cessa-
tion among self-quitters. Health Psvchology
Hughes, J. R_ Gust, S. W, Skoog, K, Keenan, R., & Fenwick, J. W.
(1991). Symptoms of tobacco withdrawal: A replication and exten-
sion. Archives of General Psychiatry 48, 52-59.
Hughes, J. R., & Hatsukami, D. K. (1986). Signs and symptoms of
tobacco withdrawal. Archives of General Psychiatry, 43, 289-294,
Hughes, J. R_ Hatsukami, D K., Pickens, R. W Krahn, D., Malin, S&
Luknic. A. (1984). Effect of nicotine on the tobacco withdrawal syn-
drome. Psvchopharmacology, 83, 82-87.
Hughes. J. R_ Hatsukami, D. K., Pickens, R. W, & Svikis, Q S. (1984).
Consistency of the tobacco withdrawal syndrome, Addictive Behav-
ion, 9, 409-412.
Hughes, J. R_ Hatsukami, D. K.. & Skoog, K. (1986). Physical depen-
dence on nicotine gum: A placebo-substitution trial. Journal of the
American Medical Association, 255, 3277-3279.
Hughes, J. R_ Higgins, S. T& Hatsukarai, D. K. (1990). Effeccs of
abstinence from tobacco: A critical teview. In L. T. Kozlowski, H.
Annis, H. D. Cappeli, F Glaser, M. Goodstadt, Y, Israel, H. Kalant,
E. M. Sellers. & J. Vingilis (Eds,), Research advances in alcohol and
drug problems (Vol. 10, pp. 317-398). New York: Plenum Press.
Hughes. J. R_ & Kottke, T. (1986). Doctors helping smokers: Real
world tactics. Minnesota Medicine, 69. 293-295.
Jarvis, M. J.. Tunstall-Pedoe, H, Feyerabend, C, Vesey, C dc Saloojee,
Y. (1987). Comparison of tests used to distinguish smokers from
non-smoken, Amencan Journal of Public Health. 77,1435-1438.
Killen, J. D" Fortmann, S. P& Newman, B. (1990). Weight change
among participants in a large sample minimal contact smoking re-
lapse prevention trial. Addictive Behaviors,15. 323-332.
Killen. J. D Fortmann. S. P Newtnan. B_ & Varadx A. (1990). Evalua-
tion of a treatment approach combining nicotine gum with self-
guided behavioral treatments for smoking relapse prevention. Jotu-
na1 of Consulting and Clinical Psychology 58, 85-92.
Klesges, R. C., Meyers, A. W, Klesges, L. M, & LaVasque, M. E. (1989).
Smoking, body weight, and their effects on smoking behavior A
comprehensive review of the literature. Psychological Bulletin, 106,
204-230.
697
Kozlowski. L. T.. Mann. R. E.. Wilkinson. D. A.. & Poulos. C. X
(1989). "Cravings" are amtbtguous: Ask about urges or desires. .4d-
dictive Behaviors, 14, 443-1345.
Mangan, G. L" & Golding. J. F (1984). The psychopharmacology of
smoking. Cambridge, England: Cambndge University Press.
Martin, W R.. & Jasinski, D. R. (1969). Physiological parameters of
morphine dependence in man. Tolerance, early abstinence and pro-
tracted abstinence. Journal of Psychiatric Research. 7. 9-17.
Nemeth-Coslett, R, Sampson, A, & Henningfield. J. E. (1986. Au-
gust). Subjective and physiological correlates of cigarette deprivation.
Paper presented at the 94th Annual Convention of the American
Psychological Association, Washington, DC.
Pechacek, T, Arken, R, & Johnson, N. J. (1982). Quit and win. Minne-
apolis. MN: Minnesota Heart Health Program.
Russell, M. A. H., Peto, J, & Patel, U. A. (1974). The classification of
smoking by factoral structure of motives. Journal ofthe Royal Statts-
tieal Society: Series A. 137, 313-333.
Schneider, N. G, dt Jarvik, M. E. (1985). Nicotine gum vs. placebo
gum: Comparisons of withdrawal symptoms and success rates. ln J.
Grabowski & S. M. Hall (Eds.), Pharmacological adjuncts in smoking
cessation (National Institute on Drug Abuse Research Monograph
53; pp. 83-101: DHHS Pub. No. ADM 85-1333). Washington, DC:
US. Government Printing Office.
U S. Department of Health and Human Services (1990). Psychological
and behavioral consequences and correlates of smoking cessation.
In Health consequences of smoking cessation: A report of the US. Sur-
geon General (pp. 521-531). Washington, DC: U.S. Government
Printing O9'ix.
Ward, K. D, GarveX A. J, & Bliss, R. E(1992). Evidence of transient
heart rate change after smoking cessation. Psyritopharmacologyt
106, 337-340.
West, R. J, Hajek, P, & Belcher, M. (1987). Time course of cigarette
withdrawal symptoms during four weeks of treatment with nicotine
gum. Addictive Behaviors. 11, 1-5.
West, R. J, Hajek, P. & Belcher, M. (1989a). Severity of withdrawal
symptoms as s predictor of outcome of an attempt to quit smoking.
Psychological Medicine. 19, 981-985,
West, R. J Hajek. P& Belcher, M. (1989b). Time course of cigarette
withdrawal symptoms. Psychopharmacology 99, 143-145.
West, R. J, dt Russell, M. A. H. (1985). Effects of withdrawal from
long-term nicotine gum use. Psychological MedicinG 15, 891-893.
West. R. J, &Schneider, N. (1987). Craving for cigarettes. British Jour-
nal of Addiction, 82, 407-415.
West, R. J, & Schneider, N. (1988). Drop in heart rate following smok-
ing cessation may be permanent. Psychopharmacologyt 94, 566-
568.
Received June 25,1991
Revision t ece>`+ed August 28, 1991
Accepted January 20,1992
